Adalta Ltd and GPCR Therapeutics collaborate on novel cancer treatment approach
AdAlta Ltd (ASX:1AD) has teamed up with clinical-stage biotech GPCR Therapeutics to investigate a new cancer treatment approach. Together, the healthcare...
Source: proactiveinvestors.com.au